KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Revenue (2016 - 2026)

Idexx Laboratories has reported Revenue over the past 17 years, most recently at $1.1 billion for Q4 2025.

  • For Q4 2025, Revenue rose 14.28% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $4.3 billion, up 10.42%, while the annual FY2025 figure was $4.3 billion, 10.42% up from the prior year.
  • Revenue for Q4 2025 was $1.1 billion at Idexx Laboratories, down from $1.1 billion in the prior quarter.
  • Over five years, Revenue peaked at $1.1 billion in Q2 2025 and troughed at $777.7 million in Q1 2021.
  • A 5-year average of $922.2 million and a median of $908.6 million in 2023 define the central range for Revenue.
  • Biggest five-year swings in Revenue: rose 29.57% in 2021 and later rose 3.43% in 2022.
  • Year by year, Revenue stood at $801.1 million in 2021, then increased by 3.43% to $828.6 million in 2022, then increased by 8.81% to $901.6 million in 2023, then rose by 5.84% to $954.3 million in 2024, then increased by 14.28% to $1.1 billion in 2025.
  • Business Quant data shows Revenue for IDXX at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.